TY - JOUR T1 - Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study. JF - Lancet Infect Dis. Y1 - 2016 A1 - Abergel, A. A1 - Asselah, T. A1 - Metivier, S. A1 - Loustaud-Ratti, V. VL - 16 SP - 459-464 IS - 4 ER -